Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to evaluate the efficacy of filgotinib and lanraplenib (previously GS-9876) in adults with lupus membranous nephropathy (LMN).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03285711
Study type Interventional
Source Gilead Sciences
Contact
Status Completed
Phase Phase 2
Start date October 6, 2017
Completion date February 3, 2020